FlexSpark Inc.

Every year in the U.S, over 10 million patients are affected by the leading cause of preventable hospital death known as Deep Vein Thrombosis, or DVT. Over 100,000 deaths per year are associated to hospital acquired DVTs, as well as over half a billion dollars in spending nationally on ineffective mechanical prophylaxis treatments. The FlexSpark DVT prevention device uses a wireless on-leg electrical muscle stimulation system that makes compliance the priority – allowing for speedier recoveries and better patient outcomes.